ROYAL BANK OF CANADA - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$0
-100.0%
1,663
+20.1%
0.00%
Q2 2022$1,000
-92.3%
1,385
-88.8%
0.00%
Q1 2022$13,000
+550.0%
12,335
+824.0%
0.00%
Q4 2021$2,000
-71.4%
1,335
-44.3%
0.00%
Q3 2021$7,000
-83.3%
2,395
-73.2%
0.00%
Q2 2021$42,000
+7.7%
8,943
+36.4%
0.00%
Q1 2021$39,000
+30.0%
6,557
+15.2%
0.00%
Q4 2020$30,000
+275.0%
5,692
+154.7%
0.00%
Q3 2020$8,000
-75.0%
2,235
-39.4%
0.00%
Q2 2020$32,000
+113.3%
3,686
+52.8%
0.00%
Q1 2020$15,000
-31.8%
2,413
-19.8%
0.00%
Q4 2019$22,000
+83.3%
3,008
+50.4%
0.00%
Q3 2019$12,000
-36.8%
2,0000.0%0.00%
Q2 2019$19,000
+216.7%
2,000
+150.0%
0.00%
Q1 2019$6,000
-53.8%
8000.0%0.00%
Q4 2018$13,000
-18.8%
800
-20.3%
0.00%
Q3 2018$16,000
+33.3%
1,004
+22.1%
0.00%
Q2 2018$12,0008220.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$7,294,0008.07%
Invus Financial Advisors, LLC 1,094,998$5,081,0001.01%
Founders Fund V Management, LLC 491,751$2,282,0000.78%
Tibra Equities Europe Ltd 80,700$374,0000.12%
GSA CAPITAL PARTNERS LLP 205,882$955,0000.11%
Hall Private Wealth Advisors 18,500$86,0000.06%
20/20 Capital Management, Inc. 42,840$199,0000.05%
OCCUDO QUANTITATIVE STRATEGIES LP 64,789$301,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 759,918$3,526,0000.02%
PDT Partners, LLC 74,178$344,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders